Selected article for: "acute myocardial infarction etiology significance and low density lipoprotein receptor"
Author: He, Yang; Cao, Lingling; Wang, Li; Liu, Lingping; Huang, Ying; Gong, Xuan
Title: Metformin Inhibits Proliferation of Human Thyroid Cancer TPC-1 Cells by Decreasing LRP2 to Suppress the JNK Pathway
  • Document date: 2020_1_6
    • ID: uzatktbf_31
    Snippet: The previous study has shown that LRP2 is mainly involved in regulations on lipoprotein transporter activity, low-density lipoprotein receptor activity, lipid metabolic process, lipoprotein transport, coronary vasculature development, aorta development, cell proliferation, ventricular septum development, clathrin-coated vesicle membrane, lysosome, etc. It is of significance in the etiology of acute myocardial infarction. 17, 18 The JNK pathway is.....
    Document: The previous study has shown that LRP2 is mainly involved in regulations on lipoprotein transporter activity, low-density lipoprotein receptor activity, lipid metabolic process, lipoprotein transport, coronary vasculature development, aorta development, cell proliferation, ventricular septum development, clathrin-coated vesicle membrane, lysosome, etc. It is of significance in the etiology of acute myocardial infarction. 17, 18 The JNK pathway is extensively involved in cellular behaviors, and its dysregulation is considered to be linked to disease progression. [19] [20] [21] In MGC-803 cells (gastric cancer cells), JNK induces apoptosis through the mitochondrial pathway, triggering cytochrome release into the cytoplasm to initiate the apoptotic pathway. 21, 22 Besides, metformin is able to activate the AMPK, mTOR/6SK, p-ERK and p70S6K/pS6 pathways. 14, 23 It is capable of suppressing mitosis and proliferation of thyroid cancer stem cells and induces apoptosis. 24 Our findings illustrated that metformin treatment inactivated the JNK pathway in TPC-1 cells, which could be abolished by overexpression of LRP2.

    Search related documents:
    Co phrase search for related documents
    • acute myocardial infarction and cell proliferation: 1, 2, 3
    • acute myocardial infarction and disease progression: 1, 2, 3, 4, 5, 6
    • apoptosis induce and cancer cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • apoptosis induce and cell proliferation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • apoptosis induce and cytochrome release: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • apoptosis induce and disease progression: 1, 2
    • apoptotic pathway and cancer cell: 1, 2, 3, 4
    • apoptotic pathway and cell proliferation: 1, 2, 3, 4
    • apoptotic pathway and cytochrome release: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • apoptotic pathway and disease progression: 1
    • cancer cell and cell proliferation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cancer cell and cytochrome release: 1, 2, 3
    • cancer cell and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cancer stem cell and cell proliferation: 1
    • cancer stem cell and cytochrome release: 1
    • cancer stem cell and disease progression: 1
    • cell proliferation and cytochrome release trigger: 1
    • cell proliferation and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell proliferation and disease progression link: 1